Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,960.00
Bid: 1,969.00
Ask: 1,971.00
Change: 35.00 (1.82%)
Spread: 2.00 (0.102%)
Open: 1,937.00
High: 1,977.00
Low: 1,931.00
Prev. Close: 1,925.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS SUMMARY: WPP Down 15% As 2020 Outlook Disappoints

Thu, 27th Feb 2020 10:49

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.

----------

FTSE 100 - WINNERS

----------

Hikma Pharmaceuticals, up 5.3%. The drugmaker said it delivered a positive financial performance in 2019. Hikma said group revenue in 2019 rose 7% to USD2.2 billion, compared to USD2.07 billion in 2018, reflecting good growth in each of the three business. Pretax profit grew to USD493 million from USD293 million in 2018, also reflecting strong performance of its three business segments. By division, Injectables revenue grew 8% to USD894 million, "driven by strong demand" for the company's portfolio. Meanwhile Generics and Branded revenue grew 4% and 8% respectively, reflecting "excellent commercial execution", reduced costs and strong demand across Middle East, North Africa region. The company declared an annual dividend of 44 cents per share, an increase from 38 cents per share in 2018. The final dividend 30 cents, up from 26 cents. Looking ahead, the company said it expects its three business segments to grow in 2020. Hikma said it does not currently anticipate any material impact from coronavirus, since it does not have extensive operations in China.

----------

RSA Insurance Group, up 2.7%. RSA reported a mixed 2019 performance, with profit coming in above market expectations, despite a fall in net written premiums. The general insurer's net written premiums for 2019 declined by 1.1% to GBP6.40 billion from GBP6.47 billion, coming in below the analyst consensus forecast of GBP6.46 billion. RSA's net written premiums were up 1% in Scandinavia and 3% in Canada, however the UK & International unit reported a 7% drop due to underwriting and rating actions taking effect. Pretax profit for the year increased by 15% to GBP551 million from GBP480 million, and well above consensus forecasts of GBP506 million. In addition, operating profit rose by 27% to GBP656 million from GBP517 million, also well above analyst expectations of GBP644 million. RSA declared a final dividend of 15.6 pence per share, brining the total dividend for 2019 to 23.1p, up 10% from 21.0p the year before.

----------

British American Tobacco, up 2.2%. The Dunhill and Rothmans cigarette maker raised its dividend after reporting mixed annual results. For 2019, BAT posted a GBP7.91 billion pretax profit, down 5.2% from 2018. While revenue rose 5.7% to GBP25.88 billion, depreciation, amortisation and impairment costs climbed 45% to GBP1.51 billion while other operating expenses were 18% higher at GBP7.85 billion. The company incurred a GBP436 million charge on a class action lawsuit in Canada, plus amortisation and impairment of trademarks totalling GBP481 million. BAT's constant currency revenue guidance was to the upper end of a guided range of 3% to 5%. BAT raised its dividend by 3.6% to 210.4 pence per share. "These are predictably solid results, which demonstrate the strength of BAT's businesses around the world. Tobacco faces many challenges currently, but BAT is navigating around them and generating substantial cash flows in the process... A restructuring programme launched last year helped margins to rise, whilst strong underlying cash flow saw debt levels falling," Hargreaves Lansdown's Steve Clayton said.

----------

Reckitt Benckiser, up 2.1%. The household goods firm raised its annual dividend as it said it was "too early" to assess the affect the coronavirus outbreak will have on future earnings. For 2019, Reckitt posted an annual loss after a huge impairment of more than GBP5 billion on goodwill related to its acquisition of Mead Johnson Nutrition. As such, Reckitt posted a pretax loss for 2019 of GBP2.11 billion, swung from a pretax profit of GBP2.72 billion the year prior. Net revenue rose 2.0% at actual exchange rates to GBP12.85 billion, and was 0.8% higher at constant rates. This compares to company-compiled consensus of GBP12.83 billion of net revenue. Reckitt declared a final dividend of 101.6 pence per share for the year, taking the year's total to 174.6p. This is 2.3% higher than the dividend of 170.7p in 2018. Reckitt has concluded a strategy review, setting up a three-phase plan targeting mid-single-digit revenue growth, margins in the mid-20s as a percentage, and 7% to 9% earnings per share growth. "All in all, these results on an adjusted basis were generally in line. The business still faces short-term uncertainties including the Covid-19 disruption in their Asian markets alongside tougher market environments globally presenting the group with a number of hurdles to overcome," commented the Share Centre.

----------

Rentokil Initial, up 1.5%. The pest control company upped its dividend by 15% following a "strong" annual performance in which it beat revenue growth targets. Rentokil declared a final dividend of 3.64 pence per share, taking the total to 5.15p, just over 15% higher than the payout in 2018. The company swung to a pretax profit of GBP338.5 million, after a loss of GBP114.1 million in 2018. Rentokil's figure last year had been hit by a pension settlement worth nearly GBP350 million. Adjusted pretax profit was 11% higher at actual exchange rates, an 9.8% at constant currency, at GBP340.9 million. Rentokil achieved 9.8% revenue growth at actual exchange rates to GBP2.71 billion, with constant currency revenue growth 8.5%. Organic revenue growth was 4.5%, beating Rentokil's medium-term target of 3% to 4% annual organic growth. Looking ahead, Rentokil said it has made a "good" start to 2020, and it has maintained medium-term growth targets.

----------

FTSE 100 - LOSERS

----------

WPP, down 15%. The advertising firm posted a double-digit profit slump but said it has made "good progress" in its restructuring plan which it is now in its second year. From continuing operations, revenue for 2019 was up 1.4% to GBP13.23 billion from GBP13.05 billion, but pretax profit slumped 22% to GBP982 million from GBP1.26 billion. The profit hit was largely due to it booking a GBP68.4 million hit from the revaluation of financial instruments, compared to a GBP169.4 million gain in 2018. Billings meanwhile, slipped 0.3% to GBP53.06 billion GBP53.22 billion. Like-for-like billings were down 1.0% in 2019. The company held its dividend at 60.0 pence per share. For 2020, WPP expects revenue less pass-through costs to be flat year-on-year, although WPP said this guidance was made prior to any impact from the coronavirus outbreak. "After a year of consolidation and modest progress, 2020 was supposed to be the year when CEO Mark Read really started to deliver, joined by newly appointed finance chief John Rogers. He is off to a very ropey start after reporting that underlying revenue slumped rather alarmingly in the fourth quarter of last year. The best investors can hope for now is zero growth and maintained margins in 2020. The targets for 2021 have been maintained but the market's patience appears to have snapped," said AJ Bell's Russ Mould.

----------

Persimmon, down 5.0%. The housebuilder's annual profit missed market expectations, with revenue and new home sales declining as the group prioritised the quality of sales over quantity. Persimmon announced Chief Executive David Jenkinson will step down in due course, staying "for as long as the business requires". For 2019, Persimmon reported pretax profit of GBP1.04 billion, down 4.6% from the year before, on revenue that declined by 2.4% to GBP3.65 billion. During the year, Persimmon delivered 15,885 new homes to customers, down 4% from 16,449 the prior year, but at an average selling price of GBP215,709, up marginally year-on-year. The revenue decline was due to a lower volumes of homes sold, as Persimmon delayed sales releases in higher demand locations to later stages of construction in order to improve the quality of the group's homes.

----------

Standard Chartered, down 3.9%. The emerging markets-focused bank reported double-digit profit growth in 2019, but said it no longer expects to achieve its medium-term target next year amid slowing economic growth. StanChart said pretax profit for 2019 increased by 46% to USD3.71 billion from USD2.55 billion reported a year earlier, as operating income grew by 4% to USD15.42 billion from USD14.79 billion. Market consensus compiled by the company forecast pretax profit at USD3.94 billion on operating income of USD15.38 billion. Operating costs were reduced, meanwhile, by 6% to USD10.93 billion from USD11.65 billion a year ago. Standard Chartered declared a final dividend of 20 cents per share, resulting in a full-year dividend of 27 cents per share, up 29% on 2018's payout. Looking ahead, the bank said "external challenges" are expected to hurt its income growth in 2020, which is now likely to be lower than the 5% to 7% medium-term range previously guided by the bank. StanChart said it will therefore take longer to achieve its 10% RoTE target, which it previously anticipated it would achieve in 2021.

----------

FTSE 250 - WINNERS

----------

Hunting, up 4.0% at 303.20 pence. The oilfield services firm announced its first ever share buyback programme and said the outlook for 2020 remains uncertain due to commodity prices. Hunting said 2019 pretax profit declined 10% to USD93.1 million from USD104.0 million. Underlying earning before interest, tax, depreciation and amortization slipped 1.8% to USD139.7 million from USD142.3 million in 2018. Revenue was USD960.0 million, a 5.4% increase from USD911.4 million in 2018. The company declared final dividend of 6 cents per share, up 20% compared to 5 cents per share a year ago. Hunting announced what it said will be its first ever share buyback programme, of 2 million shares at an approximate cost of USD8 million. This implies a price of USD4 per share, or about 311 pence.

----------

FTSE 250 - LOSERS

----------

Aston Martin Lagonda, down 14%. The luxury carmaker confirmed details of its GBP500 million funding plan after enduring a torrid 2019 that brought wider losses. Aston Martin posted a pretax loss of GBP104.3 million for the year, widening from GBP68.2 million., while revenue in 2019 fell 9% on the year before to GBP997.3 million, with wholesale volumes also down 9%, to 5,862 units. Aston Martin is launching the DBX range of SUVs in February, with total orders now in excess of the planned retail target in 2020. Looking to 2020, sports car wholesales are expected to be "materially lower" than 2019 as the company focuses on reducing dealer inventories. Adjusted earnings before interest, tax, depreciation, and amortisation is seen "almost entirely" second-half weighted in 2020. Aston Martin has also warned on the impact of coronavirus, which could impact both the supply chain and customer demand in China, as well as other markets.

----------

Playtech, down 13%. The gambling and sports betting software firm warned the coronavirus outbreak is expected to hit results for 2020, as it reported a fall in profit for 2019 on impairments. Revenue for 2019 rose 23% to EUR1.51 billion, up 22% at constant currency. Adjusted earnings before interest, tax, depreciation and amortisation was up 11% to EUR383.1 million, but pretax profit slumped to EUR48.2 million from EUR187.7 million. Profit was hit by the impairment of intangible assets of the Markets and Alpha cash generating units, totalling EUR90.1 million. In addition, depreciation and amortisation costs grew to EUR215.7 million from EUR150.7 million. Turning to current trading, core B2B Gambling revenue was up 5% on a year ago for the first 55 days of 2020. Snaitech, its B2C business in Italy, has seen strong start to 2020, the firm said, though the coronavirus outbreak has hit recent trading. Asia revenue in February is expected to be EUR7 million due to Covid-19, said Playtech.

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
4 Aug 2023 09:39

LONDON BROKER RATINGS: Jefferies raises John Wood to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
3 Aug 2023 15:45

UK dividends calendar - next 7 days

Friday 4 August 
Burberry Group PLCdividend payment date
Bytes Technology Group PLCdividend payment date
Bytes Technology Group PLCspecial dividend payment date
CC Japan Income & Growth Trust PLCdividend payment date
CT UK High Income Trust PLCdividend payment date
Ferguson PLCdividend payment date
Global Smaller Cos Trust PLCdividend payment date
Intermediate Capital Group PLCdividend payment date
JD Sports Fashion PLCdividend payment date
JPMorgan European Discovery Trust PLCdividend payment date
JPMorgan Multi-Asset Growth & Income PLCdividend payment date
Liontrust Asset Management PLCdividend payment date
Mitie Group PLCdividend payment date
NewRiver REIT PLCdividend payment date
Norcros PLCdividend payment date
North American Income Trust PLCdividend payment date
Palace Capital PLCdividend payment date
Premier Miton Group PLCdividend payment date
Regional REIT Ltddividend payment date
Schroder UK Mid Cap Fund PLCdividend payment date
Supermarket Income REIT PLCdividend payment date
Twentyfour Income Fund Ltddividend payment date
Value & Indexed Property Income Trust PLCdividend payment date
Vodafone Group PLCdividend payment date
Vp PLCdividend payment date
Workspace Group PLCdividend payment date
Monday 7 August 
no events scheduled 
Tuesday 8 August 
no events scheduled 
Wednesday 9 August 
National Grid PLCdividend payment date
Record PLCdividend payment date
Thursday 10 August 
abrdn New Dawn Investment Trust PLCex-dividend payment date
Alternative Income REIT PLCex-dividend payment date
Ashtead Group PLCex-dividend payment date
AstraZeneca PLCex-dividend payment date
Avon Protection PLCex-dividend payment date
Barclays PLCex-dividend payment date
BP PLCex-dividend payment date
Domino's Pizza Group PLCex-dividend payment date
Fresnillo PLCex-dividend payment date
Greencoat Renewables PLCex-dividend payment date
Greencoat UK Wind PLCex-dividend payment date
Halfords Group PLCex-dividend payment date
Hikma Pharmaceuticals PLCex-dividend payment date
HSBC Holdings PLCex-dividend payment date
IMI PLCex-dividend payment date
Impax Environmental Markets PLCex-dividend payment date
Informa PLCex-dividend payment date
IP Group PLCex-dividend payment date
Irish Residential Properties REIT PLCex-dividend payment date
Lindsell Train Investment Trust PLCex-dividend payment date
LMS Capital PLCex-dividend payment date
Majedie Investments PLCex-dividend payment date
Man Group PLCex-dividend payment date
NatWest Group PLCex-dividend payment date
PayPoint PLCex-dividend payment date
Pearson PLCex-dividend payment date
PRS REIT PLCex-dividend payment date
Quartix Technologies PLCex-dividend payment date
Reach PLCex-dividend payment date
Residential Secure Income PLCex-dividend payment date
Rio Tinto PLCex-dividend payment date
Safestore Holdings PLCdividend payment date
Scottish American Investment Co PLCex-dividend payment date
Segro PLCex-dividend payment date
Shell PLCex-dividend payment date
Speedy Hire PLCex-dividend payment date
Spirent Communications PLCex-dividend payment date
Standard Chartered PLCex-dividend payment date
Target Healthcare REIT PLCex-dividend payment date
Taylor Maritime Investments Ltdex-dividend payment date
Treatt PLCdividend payment date
Tritax Big Box REIT PLCex-dividend payment date
Vanquis Banking Group PLCex-dividend payment date
Vh Global Sustainable Energy Opportunities PLCex-dividend payment date
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
3 Aug 2023 09:28

Hikma posts higher interim revenue; ups guidance for Generics business

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday said it expects a higher full year performance from its Generics business amid interim revenue growth, but reported a drop in profit.

Read more
3 Aug 2023 07:51

Hikma lifts guidance for generics business

(Sharecast News) - Hikma Pharmaceuticals lifted annual revenue and margin guidance for its generics business as first-half core operating profit rose 35%.

Read more
27 Jul 2023 15:40

UK earnings, trading statements calendar - next 7 days

Friday 28 July 
AstraZeneca PLCHalf Year Results
AIB Group PLCHalf Year Results
IMI PLCHalf Year Results
Impellam Group PLCHalf Year Results
International Consolidated Airlines Group SAHalf Year Results
Intertek Group PLCHalf Year Results
Jardine Matheson Holdings LtdHalf Year Results
NatWest Group PLCHalf Year Results
PayPoint PLCFull Year Results
PayPoint PLCTrading Statement
Rightmove PLCHalf Year Results
Standard Chartered PLCHalf Year Results
Taylor Maritime Investments LtdTrading Statement
Vanquis Banking Group PLCHalf Year Results
YouGov PLCTrading Statement
Monday 31 July 
Bank of Ireland Group PLCHalf Year Results
GlobalData PLCHalf Year Results
Hutchmed (China) LtdHalf Year Results
Pearson PLCHalf Year Results
Pod Point Group Holdings PLCHalf Year Results
Quartix Technologies PLCHalf Year Results
Ricardo PLCTrading Statement
Senior PLCHalf Year Results
Spectris PLCHalf Year Results
Tuesday 1 August 
BP PLCHalf Year Results
Coats Group PLCHalf Year Results
Diageo PLCFull Year Results
Domino's Pizza Group PLCHalf Year Results
Filtronic PLCFull Year Results
Fresnillo PLCHalf Year Results
Greggs PLCHalf Year Results
HSBC Holdings PLCHalf Year Results
International Personal Finance PLCHalf Year Results
Keller Group PLCHalf Year Results
Man Group PLCHalf Year Results
Metro Bank PLCHalf Year Results
NWF Group PLCFull Year Results
Robert Walters PLCHalf Year Results
Staffline Group PLCHalf Year Results
System1 Group PLCFull Year Results
Travis Perkins PLCHalf Year Results
Virgin Wines UK PLCTrading Statement
Weir Group PLCHalf Year Results
XP Power LtdHalf Year Results
Wednesday 2 August 
BAE Systems PLCHalf Year Results
ConvaTec Group PLCHalf Year Results
Direct Line Insurance Group PLCHalf Year Results
Endeavour Mining PLCHalf Year Results
Ferrexpo PLCHalf Year Results
Haleon PLCHalf Year Results
Genel Energy PLCHalf Year Results
Ibstock PLCHalf Year Results
IP Group PLCHalf Year Results
Kerry Group PLCHalf Year Results
Permanent TSB Group Holdings PLCHalf Year Results
Smurfit Kappa Group PLCHalf Year Results
Spirent Communications PLCHalf Year Results
Taylor Wimpey PLCHalf Year Results
Virgin Money UK PLCTrading Statement
Thursday 3 August 
Coca-Cola Europacific Partners PLCHalf Year Results
Helios Towers PLCHalf Year Results
Hikma Pharmaceuticals PLCHalf Year Results
Irish Residential Properties REIT PLCHalf Year Results
London Stock Exchange Group PLCHalf Year Results
Mears Group PLCHalf Year Results
Mondi PLCTrading Statement
Morgan Sindall Group PLCHalf Year Results
Next PLCTrading Statement
Omega Diagnostics Group PLCFull Year Results
Pantheon International PLCFull Year Results
Pets At Home Group PLCQ1 Results
Rolls-Royce Holdings PLCHalf Year Results
ScS Group PLCTrading Statement
Serco Group PLCHalf Year Results
Shaftesbury Capital PLCHalf Year Results
Smith & Nephew PLCHalf Year Results
Tritax Big Box REIT PLCHalf Year Results
TT Electronics PLCHalf Year Results
Walker Crips Group PLCFull Year Results
Wizz Air Holdings PLCQ1 Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
20 Jul 2023 17:08

Commodity-heavy FTSE 100 lifted by Anglo American, China stimulus hopes

Anglo American shines after production update

*

Read more
20 Jul 2023 11:43

Hikma, Fresenius shares rally after tornado hits rival Pfizer's U.S. plant

LONDON, July 20 (Reuters) - Shares in UK pharmaceutical company Hikma rose by the most in 10 months on Thursday after tornado damage to a U.S. facility owned by competitor Pfizer boosted other drugmakers' stock.

Read more
20 Jul 2023 09:54

Shares in Pfizer rivals Hikma, Fresenius rally after tornado hits factory

LONDON, July 20 (Reuters) - Shares in UK pharmaceutical company Hikma rose by the most in 10 months on Thursday, hitting an 18-month high, following news of tornado damage to a U.S. facility owned by competitor Pfizer, which boosted other drugmakers' stock.

Read more
20 Jul 2023 08:53

Hikma surges after tornado damages Pfizer injectables plant

(Sharecast News) - Hikma Pharmaceuticals surged on Thursday, with traders pointing to news that a major Pfizer injectables plant in North Carolina was hit by a tornado and heavily damaged on Wednesday.

Read more
12 Jul 2023 09:27

LONDON BROKER RATINGS: UBS raises AstraZeneca; RBC cuts Bunzl

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
8 Jun 2023 12:03

Director dealings: Hikma non-exec invests, LSE Group share buyback rolls on

(Sharecast News) - Hikma Pharmaceuticals was among those on the list of director buys on Thursday, after a non-executive director added almost £27k worth of shares to his holding.

Read more
22 May 2023 09:23

LONDON BROKER RATINGS: Citigroup cuts Sainsbury to 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
9 May 2023 09:29

LONDON BROKER RATINGS: RBC raises Intertek; Davy likes Greencoat UK

(Alliance News) - The following London-listed shares received analyst recommendations xxxxday morning:

Read more
3 May 2023 16:16

Broker tips: HSBC, Hikma, Pearson

(Sharecast News) - Berenberg upgraded HSBC to 'buy' from 'hold' on Wednesday, keeping the price target at 780p, as it said the bank's return on tangible equity of around 13% and attractive growth potential are undervalued.

Read more
3 May 2023 12:56

RBC Capital lifts Hikma price target, reiterates 'outperform'

(Sharecast News) - RBC Capital Markets lifted its price target on Hikma Pharmaceuticals on Wednesday to 2,050p from 1,950p as it reiterated its 'outperform' rating.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.